News

A look at COVID-19 vaccines already in use, or getting close


A look at COVID-19 vaccines already in use, or getting close
In this Thursday, Jan. 21, 2021 file photo, Joseph Zalman Kleinman, 92, a Holocaust survivor, receives his second dose of the Pfizer vaccine for COVID-19, administered by Linor Attias of United Hatzalah paramedic service at the Clalit Health Services vaccination center at a sports arena in Jerusalem. While a few have already hit the market, there are still dozens of coronavirus vaccines in development around the globe. (AP Photo/Maya Alleruzzo)

While a few have already hit the market, there are still dozens of coronavirus vaccines in development around the globe.

Some use tried-and-true technologies, other use novel approaches. The shots were all tested differently, and some were allowed to go into use even before they were rigorously tested. How well they work varies, with preliminary study results ranging from 50% effective to over 90%.

Read:First hybrid gene therapy shows early promise in treating long QT syndrome

So far, regulators in different countries have allowed use of about a half dozen, mostly under emergency use provisions. A few more are getting close. The ones available now all require two doses, given weeks apart.

Among those furthest along:

Pfizer: Developed with BioNTech; authorized by the U.S., U.K, European Union, the World Health Organization and elsewhere.

Moderna: Developed with the U.S. National Institutes of Health; authorized by the U.S., U.K., European Union, the World Health Organization and elsewhere.

AstraZeneca: Developed with Oxford University; authorized by more than 40 countries, including Britain, India, Argentina, Mexico and the European Union.

Sputnik V: Developed by Russia’s Gamaleya Research Institute; authorized in Russia and about 10 other countries.

Sinopharm: Authorized in China and several countries including Hungary, Serbia, and Morocco.

Sinovac: Authorized in China as well as Turkey, Brazil and Indonesia.

Bharat Biotech: Authorized in India.

Johnson & Johnson: In development; one dose; expected to seek U.S. Food and Drug Administration authorization soon.

Novavax: In development.

Read:Poor nutrition in school years may have created 20 cm height gap across nations

Follow the latest news on the coronavirus (COVID-19) outbreak


© 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

Read:No Europe deaths directly tied to Covid jabs: experts

Citation:
A look at COVID-19 vaccines already in use, or getting close (2021, January 30)
retrieved 30 January 2021
from https://medicalxpress.com/news/2021-01-covid-vaccines-2.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.





Source link

Previous post
Host immune classifier HIC assays may predict treatment response
Next post
Radiation Oncology trials using PET with FDG uptake among NSCLC patients